Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in hepatocellular carcinoma clinical research, as well as the reasons for withdrawal or discontinuation. Insights gained from this study will ultimately benefit those with hepatocellular carcinoma who may be invited to participate in clinical research in the years to come.
Study Type
OBSERVATIONAL
Enrollment
500
Rate of patients who decide to enroll in a hepatocellular carcinoma clinical study.
Time frame: 3 months
Number of hepatocellular carcinoma study participants who remain in clinical trial until completion.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.